Certified by Founder
Lodge
Eligo Bioscience
start up
France
- Paris, Il de France
- 06/12/2023
- Series B
- $30,000,000
Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing.
- Industry Biotechnology Research
- Website https://eligo.bio/
- LinkedIn https://www.linkedin.com/company/eligo-bioscience/about/
Related People
Xavier DuportetCo Founder
France -
Paris, Île-de-France
I am an engineer and a geneticist, turned entrepreneur.
Zócalo Health | $15,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Brev.io | $3,300,000 | (Apr 24, 2026)
Maxed | $850,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
Astor (YC S25) | $5,000,000 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
Petual | $20,000,000 | (Apr 24, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)